+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

HD-RI First results of a randomized trial comparing aggressive chemotherapy with high-dose therapy and hematopoietic stem cell transplantation in patients with chemosensitive relapse of Hodgkins disease



HD-RI First results of a randomized trial comparing aggressive chemotherapy with high-dose therapy and hematopoietic stem cell transplantation in patients with chemosensitive relapse of Hodgkins disease



Blood 90(10 SUPPL 1 PART 1): 115A, Nov 15




(PDF emailed within 1 workday: $29.90)

Accession: 031633799

Download citation: RISBibTeXText


Related references

Adult Burkitts and Burkitt-like non-Hodgkins lymphoma Favourable outcome for patients undergoing high dose therapy and autologous stem cell transplantation in first remission or chemosensitive relapse Results from the EBMT. Blood 86(10 SUPPL 1): 211A, 1995

High dose therapy and autologous stem cell transplantation for adults with Hodgkins disease in first relapse after chemotherapy Conventional dose salvage therapy prior to ASCT has no effect on outcome Results from the EBMT. Blood 88(10 SUPPL 1 PART 1-2): 486A, 1996

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial. Lancet 359(9323): 2065-2071, 2002

Randomized Phase II trial of two high-dose chemotherapy regimens with stem cell transplantation for the treatment of advanced ovarian cancer in first remission or chemosensitive relapse: a Southwest Oncology Group study. Gynecologic Oncology 94(1): 98-106, 2004

Phase II trial of rituximab as adjuvant therapy to high dose chemotherapy and peripheral blood stem cell transplantation for relapsed and refractory aggressive non-Hodgkins lymphomas. Blood 98(11 Part 1): 862a, November 16, 2001

High dose chemotherapy with peripheral blood stem cell transplantation for patients with relapsed/refractory Hodgkins disease and non-Hodgkins lymphoma A randomized phase III comparison of two regimens. Blood 96(11 Part 1): 482a, November 16, 2000

Phase I Study of Involved Field Radiation Therapy Preceding High Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with High Risk Hodgkins Disease and Non-Hodgkins Lymphoma. Blood 100(11): Abstract No 3405, November 16, 2002

High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trial. Bone Marrow Transplantation 41(6): 547-554, 2007

A Phase II Trial of Front-Line Double High Dose Chemotherapy with DICEP Then BEAM and Autologous Stem Cell Transplantation as Induction Therapy for Poor Prognosis Aggressive Non-Hodgkins Lymphoma. Blood 100(11): Abstract No 2539, November 16, 2002

High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial. Journal of Clinical Oncology 22(12): 2273-2283, 2004

Elderly patients with aggressive Non-Hodgkins Lymphoma An age adjusted high dose chemotherapy with autologous stem cell transplantation allows an adequate PBPC yield with low toxicity and promising results. Blood 98(11 Part 2): 400b-401b, November 16, 2001

Second International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkins lymphomas Report of the jury. Journal of Clinical Oncology 17(1): 423-429, 1999

Effectiveness of high dose therapy and autologous stem cell transplantation as a component of first line therapy for aggressive non-hodgkins lymphoma Results of a systematic review of trials including 1083 patients. Blood 90(10 SUPPL 1 PART 1): 381A, Nov 15, 1997

High-dose therapy and autologous stem cell transplantation in Hodgkins disease patients who progress after primary chemotherapy. Bone Marrow Transplantation 15(SUPPL 1): S229, 1995

Phase I clinical trial of Zevalin in patients with B-cell non-Hodgkins lymphoma with relapsed disease following high-dose chemotherapy and autologous stem cell transplantation. Blood 102(11): 30a, November 16, 2003